Latest Biotech Stock Investment News

05/10/2021

Creso Pharma Shares Jumps 12% after Securing New Purchase Orders (ASX:CPH)

The Creso Pharma [ASX:CPH] shares soared in early morning trade after the company announced its wholly-owned Canadian subsidiary, Mernova, secured over $800,000 in new purchase orders.

Kiryll Prakapenka

30/09/2021

MGC Pharmaceuticals Share Price Up on Order Announcement (ASX:MXC)

MGC Pharmaceuticals Ltd [ASX:MXC] share price is currently up 6.90%. The MGC Pharmaceuticals Ltd [ASX:MXC] announced that its distribution partner placed an order for 1,000 units of MXC’s CimetrA on an expedited basis.

Kiryll Prakapenka

14/09/2021

MGC Pharmaceuticals Shares Lift on Landmark UK Import Permit (ASX:MXC)

MGC Pharmaceuticals said this marks the first time an epilepsy treatment containing THC and still undergoing clinical trials was approved by UK authorities for import. The news saw MGC Pharmaceuticals [ASX:MXC] shares jump 10% at the time of writing.

Kiryll Prakapenka

13/09/2021

Hazer Share Price Sinks on $7 Million Capital Raise Update (ASX:HZR)

The Hazer Group [ASX:HZR] share price sinks as the hydrogen tech developer completes a $7 million placement. Hazer will also invite eligible shareholders to participate in a share purchase plan to raise up to $7 million.

Kiryll Prakapenka

10/09/2021

Rhinomed Share Price Surges 20% on Government Deal (ASX:RNO)

The Rhinomed [ASX:RNO] share price is soaring this morning after the Victorian Department of Health placed initial orders for one million Rhinoswabs for SARS-CoV-2 testing.

Kiryll Prakapenka

01/09/2021

Imugene Share Price Sink 7% after Flagging Three New Trials (ASX:IMU)

The Imugene [ASX:IMU] share price is floundering today on the back of an announcement regarding its HER-Vaxx immunotherapy in HER-2 positive gastric cancer trial.

Ryan Clarkson-Ledward

01/09/2021

7% Up For Immutep Share Price — Progresses Clinical Trials (ASX:IMM)

Small-cap biotech stock Immutep Ltd [ASX:IMM] is on the up today. The IMM share price is currently trading 7.92% higher at time of writing...

Kiryll Prakapenka

31/08/2021

Mesoblast Shares Tumble as Losses Widen (ASX:MSB)

The MSB share price down 14%. The Mesoblast [ASX:MSB] posted a FY21 net loss of $98.8 million as the FDA asks for further trials of MSB’s emergency COVID treatment...

Kiryll Prakapenka

24/08/2021

Alcidion Posts Record FY21 Revenue but Shares Slide (ASX:ALC)

The Alcidion Group [ASX:ALC] reported record revenue for FY21 of $25.9 million. The record revenue was not enough to increase the ALC shares price, with the Alcidion stock currently down 1.5%.

Murray Dawes

23/08/2021

Trader’s Corner — Earnings Season Winners

Redbubble Ltd has had a wild ride over the past year, with a 1,300% rally from 50 cents to $7.22 in 10 months due to a leap in sales during the COVID shutdowns.